FMR LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 120 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$21,390,000
-64.1%
17,250,368
-10.7%
0.00%
-62.5%
Q1 2017$59,504,000
-25.0%
19,319,568
-0.6%
0.01%
-27.3%
Q4 2016$79,325,000
-35.6%
19,442,391
+0.3%
0.01%
-31.2%
Q3 2016$123,102,000
+19.2%
19,386,119
+1.2%
0.02%
+14.3%
Q2 2016$103,265,000
-29.1%
19,158,769
+10.1%
0.01%
-30.0%
Q1 2016$145,714,000
+6.4%
17,409,085
+0.4%
0.02%
+11.1%
Q4 2015$136,956,000
-3.7%
17,336,119
+3.7%
0.02%
-10.0%
Q3 2015$142,226,000
-30.3%
16,712,869
+1.3%
0.02%
-23.1%
Q2 2015$204,068,000
+6.4%
16,503,650
+2.3%
0.03%
+8.3%
Q1 2015$191,737,000
+6.8%
16,139,452
+1.6%
0.02%
+4.3%
Q4 2014$179,473,000
+30.3%
15,882,620
+1.2%
0.02%
+21.1%
Q3 2014$137,742,000
+21.8%
15,688,138
+1.1%
0.02%
+26.7%
Q2 2014$113,074,000
+44.9%
15,510,772
+0.1%
0.02%
+36.4%
Q1 2014$78,059,000
-4.8%
15,487,768
+0.9%
0.01%
-8.3%
Q4 2013$81,980,000
+38.4%
15,352,128
-1.5%
0.01%
+33.3%
Q3 2013$59,255,000
-44.7%
15,593,412
-2.1%
0.01%
-50.0%
Q2 2013$107,245,00015,935,2580.02%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 775,571$2,389,0000.93%
KEMPNER CAPITAL MANAGEMENT INC. 148,985$459,0000.31%
Yakira Capital Management, Inc. 248,420$765,0000.27%
GARRISON BRADFORD & ASSOCIATES INC 87,700$270,0000.24%
Cannell & Co. 1,212,478$3,734,0000.13%
LeJeune Puetz Investment Counsel LLC 3,976$180,0000.13%
ALPINE WOODS CAPITAL INVESTORS, LLC 726,000$2,236,0000.12%
Virtus ETF Advisers LLC 198,735$612,0000.11%
STONERIDGE INVESTMENT PARTNERS LLC 199,227$614,0000.08%
Birchview Capital, LP 44,000$136,0000.08%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders